Dadachanji Group Expands Capabilities with Launch of KAIRISH Innotech

With over 35 years of leadership in pharmaceutical manufacturing and allied technologies, the Dadachanji Group officially launched KAIRISH Innotech, a next-generation engineering and technology company focused on delivering fully customised machines, medical devices, and automation solutions for the pharmaceutical, healthcare, and broader industrial sectors. The launch event brought together industry leaders, partners, clients, and stakeholders to witness the unveiling of a company designed to transform how pharmaceutical infrastructure and engineering solutions are imagined, engineered, and manufactured. More than just a new venture, KAIRISH Innotech marks a strategic expansion of the Group’s capabilities into advanced, technology-led manufacturing.

Turning the ‘Make in India’ Vision into Reality

Kairus Dadachanji highlighted, “We are proud to say that the Make in India vision is being realised through KAIRISH Innotech — not merely as a slogan, but as a living, working example. With KAIRISH Innotech, we bring world-class engineering to India. You just need to envision it, and we will make it a reality. We take complete ownership of the design, development, and manufacturing of customised machines, medical devices, tooling, robotics, and automation solutions.” By localising advanced engineering expertise and reducing dependency on imports, the company aims to deliver global-quality solutions built entirely in India.

A Fully Integrated Engineering and Manufacturing Hub

KAIRISH Innotech operates as a technology-driven, end-to-end manufacturing ecosystem. Unlike conventional vendors, the company offers comprehensive capabilities under one roof, enabling seamless execution across the entire project lifecycle.

Its core offerings include:

*Customised pharmaceutical machinery

*Medical device design and manufacturing

*Tooling and precision components

*Robotics and industrial automation systems

*Fabricated equipment and sterilisation solutions

From early-stage concept design to prototyping, validation, and final production, KAIRISH Innotech functions as a single-window engineering partner, helping clients rapidly convert ideas into commercially deployable solutions.

Built for Innovation, Designed for Customisation

The company addresses a long-standing industry challenge — adapting standard machines to specialised processes. Instead of forcing fitments or modifications, KAIRISH Innotech builds equipment from the ground up based on specific operational needs.

Rishad Dadachanji commented, “KAIRISH Innotech was built to remove the limitations companies face when adapting standard equipment to specialised processes. We wanted to create a company where innovation begins at the drawing board and ends in a fully functioning, future-ready machine on the client’s floor.” This approach enables faster implementation, higher efficiency, and improved operational reliability.

An Advanced Facility for Bespoke Engineering Solutions

Positioned as one of India’s most advanced engineering facilities for application-specific machine building, KAIRISH Innotech focuses on delivering highly tailored solutions that standard equipment often cannot provide.

The company carefully aligns each system with:

*Unique facility layouts

*Throughput and production targets

*Desired automation levels

*Long-term scalability and expansion plans

As a result, clients across pharmaceuticals, healthcare, and industrial manufacturing can build smarter, future-ready production environments that evolve with their business needs.

Driving the Future of Pharmaceutical and Industrial Automation

As reported by tribuneindia.com, with the launch of KAIRISH Innotech, the Dadachanji Group strengthens its position as a forward-looking engineering partner committed to innovation, precision, and indigenous manufacturing excellence. By combining advanced design capabilities, automation expertise, and integrated manufacturing, the company is set to play a pivotal role in shaping India’s next phase of pharmaceutical and industrial infrastructure development.